Sponsor content
229 result(s) found, displaying 31 to 40
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 5/2.5 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 80/40 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 2.5/1.25mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 10/5 mg modified release tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 60/30 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 15/7.5mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 30/15mg modified release tablet blister pack.
-
Australian Public Assessment Report (AusPAR)AusPAR for Eligard (Leuprorelin acetate) for the treatment of children with central precocious puberty (CPP).
-
Cancellation by sponsorRequested by Mundipharma Pty Ltd